STAT2 and Familial prostate cancer: The data acquired in STAT2‐deficient PC‐3 cells almost completely recapitulated the antitumor phenotypes elicited by TRIM66 knockdown, which implicated the important role of STAT2 in mediating the oncogenic activities of TRIM66 in prostate cancer cells.